Download Full Text (938 KB)
- Despite Initial Setbacks, Researchers Are Focusing on Antiangiogenic Therapy More Than Ever
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Response to Antiangiogenesis Agents
- "Smart Bombs": Targeted Therapies Home in on Increasingly Well-Defined Targets
- House Call: Understanding Angiogenesis
- DiaLog: Gene Therapy for Cancer: Safety First, by Jack Roth, MD, Chair, Department of Thoracic and Cardiovascular Surgery
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
History of Science, Technology, and Medicine | Oncology
O'Suilleabhain, Kate; Matias, Katie Prout; and Roth, Jack MD, "OncoLog Volume 49, Number 06, June 2004" (2004). OncoLog MD Anderson's Report to Physicians (All issues). 126.
Conditions Governing Access